Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. [electronic resource]

By:

Camarasa, J M

Contributor(s):

Aliaga, A
Fernández-Vozmediano, J M
Fonseca, E
Iglesias, L
Tagarro, I

Producer: 20010621Description: 77-86 p. digitalISSN:

1422-2868

Subject(s):

Adolescent
Adult
Aged
Butyrophenones -- therapeutic use
Chronic Disease
Double-Blind Method
Female
Histamine H1 Antagonists -- administration & dosage
Humans
Male
Middle Aged
Phthalazines -- administration & dosage
Piperidines -- therapeutic use
Pruritus -- drug therapy
Quality of Life
Skin -- pathology
Urticaria -- drug therapy

Online resources:

Available from publisher's website

In: Skin pharmacology and applied skin physiology vol. 14

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

There are no comments on this title.

Browse results Close

Back to results

1 Role of water on unfolding kinetics of helical peptides studied by molecular dynamics simulations.
by Doruker, P
2 Collective motions of RNA polymerases. Analysis of core enzyme, elongation complex and holoenzyme.
by Yildirim, Y
3 Dynamics of proteins predicted by molecular dynamics simulations and analytical approaches: application to alpha-amylase inhibitor.
by Doruker, P
4 The elastic network model reveals a consistent picture on intrinsic functional dynamics of type II restriction endonucleases.
by Uyar, A

Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.

APA

Camarasa J. M., Aliaga A., Fernández-Vozmediano J. M., Fonseca E., Iglesias L. & Tagarro I. (20010621). Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. : Skin pharmacology and applied skin physiology.

Chicago

Camarasa J M, Aliaga A, Fernández-Vozmediano J M, Fonseca E, Iglesias L and Tagarro I. 20010621. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. : Skin pharmacology and applied skin physiology.

Harvard

Camarasa J. M., Aliaga A., Fernández-Vozmediano J. M., Fonseca E., Iglesias L. and Tagarro I. (20010621). Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. : Skin pharmacology and applied skin physiology.

MLA

Camarasa J M, Aliaga A, Fernández-Vozmediano J M, Fonseca E, Iglesias L and Tagarro I. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial. : Skin pharmacology and applied skin physiology. 20010621.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC